Mark Chen Selected Research

Neoplasm Metastasis (Metastasis)

1/2019

The Fusion Oncogene FUS-CHOP Drives Sarcomagenesis of High-Grade Spindle Cell Sarcomas in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Chen Research Topics

Disease

15	Neoplasms (Cancer) 07/2022 - 11/2004
4	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 10/2017
4	Inflammation (Inflammations) 01/2014 - 08/2008
3	Myxoid Liposarcoma 10/2021 - 01/2019
3	Human Influenza (Influenza) 01/2019 - 06/2010
2	COVID-19 01/2022 - 01/2021
2	Brain Neoplasms (Brain Tumor) 01/2021 - 07/2009
2	Disease Progression 01/2021 - 01/2013
2	Glioma (Gliomas) 01/2021 - 11/2004
2	Neurofibrosarcoma (MPNST) 01/2020 - 01/2018
2	Liver Neoplasms (Liver Cancer) 03/2011 - 07/2009
1	Melanoma (Melanoma, Malignant) 07/2022
1	Infections 02/2022
1	Carcinogenesis 10/2021
1	Genetic Translocation (Chromosomal Translocation) 10/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Diffuse Intrinsic Pontine Glioma 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Genomic Instability 01/2019
1	Fatty Liver 01/2014
1	Otitis Media 01/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2014
1	Edema (Dropsy) 07/2012
1	Alzheimer Disease (Alzheimer's Disease) 07/2012
1	Carcinoma (Carcinomatosis) 03/2011
1	Breast Neoplasms (Breast Cancer) 07/2009
1	Gliosarcoma 03/2006

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 01/2020 - 08/2008
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2022 - 01/2018
2	Oncogene Proteins (Oncogene Protein)IBA 10/2021 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 03/2011
2	VaccinesIBA 01/2019 - 06/2010
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2009 - 03/2009
1	Immune Checkpoint InhibitorsIBA 07/2022
1	Neutralizing AntibodiesIBA 02/2022
1	Viral RNAIBA 01/2022
1	AerosolsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	PrionsIBA 10/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	dipinacoline glutamateIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	Sodium-Hydrogen Exchanger 3IBA 11/2019
1	F-Box-WD Repeat-Containing Protein 7IBA 11/2019
1	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2019
1	TrabectedinIBA 03/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	trametinibIBA 01/2018
1	capmatinibIBA 01/2018
1	Site-specific recombinaseIBA 10/2017
1	Cre recombinaseIBA 10/2017
1	Recombinases (Recombinase)IBA 07/2017
1	Small Interfering RNA (siRNA)IBA 07/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Neuraminidase (Sialidase)IBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	SuspensionsIBA 01/2014
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 01/2014
1	Triglycerides (Triacylglycerol)IBA 01/2014
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2014
1	EicosanoidsIBA 01/2014
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2014
1	Oseltamivir (Tamiflu)FDA Link 01/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2013
1	Amyloid (Amyloid Fibrils)IBA 07/2012
1	Apolipoprotein E4IBA 07/2012
1	NanodiamondsIBA 03/2011
1	CytokinesIBA 10/2009
1	6- ((3- chloro)anilino)- 2- (isopropyl- 2- hydroxyethylamino)- 9- isopropylpurineIBA 07/2009
1	afimoxifene (hydroxytamoxifen)IBA 07/2009
1	DiamondIBA 03/2009
1	Collagen Type I (Type I Collagen)IBA 03/2009
1	MicellesIBA 08/2008
1	Vascular Endothelial Growth Factor DIBA 03/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2006
1	Biomarkers (Surrogate Marker)IBA 03/2006
1	NucleotidesIBA 11/2004
1	EnzymesIBA 11/2004
1	ProdrugsIBA 11/2004
1	uracil phosphoribosyltransferaseIBA 11/2004
1	Cytosine DeaminaseIBA 11/2004
1	Fluorouracil (Carac)FDA LinkGeneric 11/2004

Therapy/Procedure

6	Therapeutics 07/2022 - 11/2004
4	Radiotherapy 10/2021 - 01/2019
1	Molecular Targeted Therapy 07/2022
1	Immunotherapy 07/2022
1	Length of Stay 01/2021
1	Ambulatory Care (Outpatient Care) 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Extracorporeal Membrane Oxygenation 01/2014
1	Salvage Therapy 01/2014